These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16988741)

  • 1. ACE inhibitor use and the long-term risk of renal failure in diabetics.
    Woo KT; Lau YK; Wong KS; Chan CM
    Kidney Int; 2006 Oct; 70(7):1376-7; author reply 1378. PubMed ID: 16988741
    [No Abstract]   [Full Text] [Related]  

  • 2. ACE inhibitor use and the increased long-term risk of renal failure in diabetes.
    Hamming I; Goor Hv; Navis GJ
    Kidney Int; 2006 Oct; 70(7):1377-8; author reply 1378. PubMed ID: 16988743
    [No Abstract]   [Full Text] [Related]  

  • 3. ACE-inhibitor use and the long-term risk of renal failure in diabetes.
    Suissa S; Hutchinson T; Brophy JM; Kezouh A
    Kidney Int; 2006 Mar; 69(5):913-9. PubMed ID: 16518351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibitors and renal failure in diabetes.
    Hiremath S; Zimmerman D; Knoll GA
    Kidney Int; 2006 Oct; 70(7):1377; author reply 1378. PubMed ID: 16988744
    [No Abstract]   [Full Text] [Related]  

  • 5. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Can progression to terminal renal insufficiency be avoided in diabetic nephropathy?].
    Luño J; Valderrábano F
    An Med Interna; 1998 Nov; 15(11):567-71. PubMed ID: 9882851
    [No Abstract]   [Full Text] [Related]  

  • 7. Should all Pima Indians with type 2 diabetes mellitus be prescribed routine angiotensin-converting enzyme inhibition therapy to prevent renal failure?
    Kiberd BA; Jindal KK
    Mayo Clin Proc; 1999 Jun; 74(6):559-64. PubMed ID: 10377929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACE inhibitors as a shield against diabetic nephropathy.
    Materson BJ
    Arch Intern Med; 1996 Feb; 156(3):239-40. PubMed ID: 8572832
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal protection in diabetes.
    Hunter JD; Ravert PK; Lassetter JH; Williams M
    Adv NPs PAs; 2011 Jan; 2(1):25-9; quiz 30. PubMed ID: 21329229
    [No Abstract]   [Full Text] [Related]  

  • 10. Arterial hypertension and proteinuria in pediatric chronic kidney disease.
    Simonetti GD; Bucher BS; Tschumi S; Lava SA; Bianchetti MG
    Minerva Pediatr; 2012 Apr; 64(2):171-82. PubMed ID: 22495191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be?
    Hollenberg NK; Epstein M
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1046-8. PubMed ID: 17699325
    [No Abstract]   [Full Text] [Related]  

  • 12. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention and remission of diabetic nephropathy].
    Sugimoto T; Nakamura Y; Makino H
    Nihon Rinsho; 2003 Jul; 61(7):1167-71. PubMed ID: 12877079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nephroprotection, fact or fiction?].
    Krummel T; Faller AL; Bazin D; Hannedouche T
    Presse Med; 2011 Nov; 40(11):1037-42. PubMed ID: 21981881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is renoprotection with RAAS blockade a failed paradigm? Have we learnt any lessons so far?
    Onuigbo MA
    Int J Clin Pract; 2010 Sep; 64(10):1341-6. PubMed ID: 20716141
    [No Abstract]   [Full Text] [Related]  

  • 16. [Nephrology update. Kidney protection with antihypertensive drugs: I].
    Stein G; Fünfstück R; Sperschneider H; Ritz E
    Med Klin (Munich); 2002 Sep; 97(9):541-6. PubMed ID: 12371082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephropathy in patients with type 2 diabetes mellitus.
    Ritz E; Orth SR
    N Engl J Med; 1999 Oct; 341(15):1127-33. PubMed ID: 10511612
    [No Abstract]   [Full Text] [Related]  

  • 18. [Angiotensin II type-1 receptor antagonists and diabetes mellitus].
    Schnack C; Schernthaner G
    Wien Med Wochenschr; 2001; 151(7-8):165-8. PubMed ID: 11450165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Best practice for hypertensive patients with kidney disease.
    de Zeeuw D
    Hosp Med; 2003 Feb; 64(2):96-100. PubMed ID: 12619337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. To pay or not to pay? A decision and cost-utility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy.
    Clark WF; Churchill DN; Forwell L; Macdonald G; Foster S
    CMAJ; 2000 Jan; 162(2):195-8. PubMed ID: 10674051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.